UNITED THERAPEUTICS Corp — Director's Dealing 2019

Jan 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2019-01-18

Reporting Person: ROTHBLATT MARTINE A (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-18	Common Stock	M	7054	$52.65	Acquired	7194	Direct
2019-01-18	Common Stock	S	5815	$115.0627	Disposed	1379	Direct
2019-01-18	Common Stock	S	1239	$115.573	Disposed	140	Direct
2019-01-22	Common Stock	M	7054	$52.65	Acquired	7194	Direct
2019-01-22	Common Stock	S	4995	$113.1736	Disposed	2199	Direct
2019-01-22	Common Stock	S	1959	$113.7181	Disposed	240	Direct
2019-01-22	Common Stock	S	100	$115.15	Disposed	140	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-18	Stock Options	$52.65	M	7054	Disposed	2019-12-31	Common Stock (7054)	Direct
2019-01-22	Stock Options	$52.65	M	7054	Disposed	2019-12-31	Common Stock (7054)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166	Indirect
Common Stock	683489	Indirect

Footnotes

F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan (the "plan") entered into by the reporting person. The plan is designed to exercise and sell up to 148,138 stock options (which expire at the end of 2019) during the month of January 2019, in equal tranches of approximately 7,055 shares per day assuming certain conditions are met.

F2: This transaction was executed in multiple trades at prices ranging from $114.52 to $115.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $115.53 to $115.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $112.52 to $113.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $113.52 to $114.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.